Cleared Traditional

K963503 - CTS MIDCAB CORONARY SHUNT

K963503 is an FDA 510(k) clearance for CTS MIDCAB CORONARY SHUNT, manufactured by Cardiothoracic Systems, Inc.. The device is a Class 2 Cardiovascular device with product code DXC cleared through the Traditional 510(k) pathway after a 212-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1997
Decision
212d
Days
Class 2
Risk

K963503 is an FDA 510(k) clearance for the CTS MIDCAB CORONARY SHUNT. Classified as Clamp, Vascular (product code DXC), Class II - Special Controls.

Submitted by Cardiothoracic Systems, Inc. (Cupertino, US). The FDA issued a Cleared decision on April 3, 1997 after a review of 212 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4450 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Cardiothoracic Systems, Inc. devices

FDA 510(k) Submission Details - K963503

510(k) Number K963503 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 03, 1996
Decision Date April 03, 1997
Days to Decision 212 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
87d slower than avg
Panel avg: 125d · This submission: 212d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXC Device Classification - Class 2, Special Controls

Product Code DXC Clamp, Vascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXC Clamp, Vascular

All 105
Devices cleared under the same product code (DXC) and FDA review panel - the closest regulatory comparables to K963503.
FAVC-M: FEMORAL ARTERY VASCULAR CLAMP-MOBILE (MODEL M100-M200) FAVC-M FEMORAL ARTERY VASCULAR CLAMP-MOBILE ADJ BELT 6005
K970027 · Rmds, Inc. · Aug 1997
OCCLUSION CLAMP** DEVICE
K964251 · United States Surgical, A Division of Tyco Healthc · May 1997
HEARTPORT ENDOAORTIC CLAMP
K964161 · Heartport, Inc. · Apr 1997
FAVC: FEMORAL ARTERY VASCULAR CLAMP - MODEL NUMBER RMDS 1000-15, RMDS 1000-20, RMDS 2000-15, RMDS 2000-20, RMDS 3000-15
K964662 · Rmds, Inc. · Feb 1997
DEGANIA SILICONE INDENTI LOOPS
K964547 · Degania Silicone , Ltd. · Jan 1997
HEARTPORT CABLE BULLDOG CLAMP
K962366 · Heartport, Inc. · Nov 1996